|
WO2014169226A2
|
|
Methods of diagnosing and treating chronic pain
|
|
US2014314746A1
|
|
Methods for treating or preventing fibrosis in subjects afflicted with scleroderma
|
|
WO2014059248A1
|
|
Mir-155 enhancement of cd8+ t cell immunity
|
|
US2015011569A1
|
|
NOVEL P13K p110 INHIBITORS AND METHODS OF USE THEREOF
|
|
WO2013013043A1
|
|
Compositions and methods for diagnosing hypercoagulability and hypocoagulability
|
|
WO2012170396A1
|
|
Spla2 monitoring strip
|
|
WO2012159020A1
|
|
Methods of diagnosing neuropathic pain
|
|
WO2013105985A1
|
|
Small molecule inhibitors of rad51 recombinase and methods thereof
|
|
WO2012078752A2
|
|
Serine protease inhibitor kazal antibodies
|
|
EP2648754A2
|
|
Methods of inhibiting metastasis from cancer
|
|
WO2012006220A1
|
|
Treatment of avian species with inhibitors of p110 delta signaling
|
|
WO2011163593A2
|
|
Induction of immune response
|
|
WO2011139637A1
|
|
Small-molecule modulators of hiv-1 capsid stability and methods thereof
|
|
WO2011139636A1
|
|
Small molecule inhibitors of functions of the hiv-1 matrix protein
|
|
WO2011139525A1
|
|
Stereoisomer of naloxone and potential therapeutic action of opioid drugs to reverse clinical tolerance to these agents
|
|
US2011256538A1
|
|
Epigenomic dna modifications for tissue typing, early cancer detection, and disease management
|
|
WO2011126804A1
|
|
Uses of chec peptides to treat neurological and cardiovascular diseases and disorders
|
|
US2011135655A1
|
|
Role of PI3K p110 delta Signaling in Retroviral Infection and Replication
|
|
WO2010151675A1
|
|
Active cores of peptide triazole hiv-1 entry inhibitors
|
|
WO2010083163A1
|
|
The role of p110 delta signaling in morbidity and lung pathology induced by influenza virus infection
|
